Biotech RadarJobs updated

COMPANY

Wren Laboratories

HQ: Branford, CT source · wrenlaboratories.com ↗

Keywords: oncology liquid biopsy PCR Neuroendocrine Tumor Prostate Cancer (Adenocarcinoma) Prostate Biopsy Prostatectomy Radioligand Chemotherapy Androgen Deprivation Therapy Gastroenteropancreatic Prostate Cancer Urology Prostate Cancer (Diagnosis) Carcinoid Neuroendocrine Carcinoma Endometriosis PROSTest NETest

Location: Branford, CT · source · Oct 14, 2026

Profile checked Oct 10, 2026

5Trials (company is sponsor)

Timeline

  1. Trial start —: A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth source ↗
  2. Trial start —: RNA Assays for Endometriosis Detection and Diagnosis source ↗
  3. Trial start —: RegisterPROS - A Registry for Prostate Cancers source ↗
  4. Trial start Not phased (device or behavioral study): Surgical Intervention and the NETest source ↗
  5. Trial start —: RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 5

RecordTitlePhaseStatusStartPrimary completion
NCT06872619RegisterPROS - A Registry for Prostate CancersNot listedEnrolling by invitationJan 15, 2020Dec 15, 2028 (estimated)
NCT03012789Surgical Intervention and the NETestNot phased (device or behavioral study)CompletedMay 15, 2017Dec 1, 2025 (actual)
NCT07454603A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground TruthNot listedRecruitingApr 15, 2026Feb 28, 2027 (estimated)
NCT02270567RegisterNET - A Registry for Neuroendocrine Tumors in the USA and WorldwideNot listedEnrolling by invitation2015-022018-03 (actual)
NCT06907303RNA Assays for Endometriosis Detection and DiagnosisNot listedEnrolling by invitationJan 1, 2024Aug 31, 2025 (estimated)
Feedback